Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-11-07

Clinical Trial Update: Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma [NA]

View source ↗

Summary

Clinical trial evaluating the effect of omalizumab (Xolair) in patients with aspirin-exacerbated respiratory disease and allergic asthma; current status is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xolair (omalizumab)

Snippet

Sponsor: Scripps Clinic | Conditions: Asthma, Allergic Rhinitis | NA | Status: UNKNOWN